Authors
Latest:
How Packaging and Delivery Technologies Influence the Commercialization of Injectable DrugsOften mistakenly considered an afterthought, today’s packaging and delivery systems can powerfully affect the safety, efficacy and commercial success of injectables
Latest:
Preparing the Market for a New Drug with an Effective 'Medical Affairs Launch'The Medical Affairs function can play a vital role in today’s product launch process
Latest:
Specialty drugs are generating a new paradigm: Commercial InnovationSpecialty drug market success requires patient-focused and therapy-specific channel and services strategies
Latest:
Get better at managing clinical trial financialsControl of costs and accounting during clinical trials is a well-known challenge to sponsors. Tools are available
Latest:
Use data analytics to monitor 340B discount drug pricingDiscerning how and where products are discounted is an expensive headache for manufacturers
Latest:
Regulatory Focus on Off-Label Promotion Is RisingWhile FDA guidance on appropriate medical communication has evolved, US Dept. of Justice attention the practice is intensifying
Latest:
Value frameworks are here: What to do about them?A host of evaluation methodologies are defining ‘value’ in drug prices
Latest:
Improving Patient Services and Outcomes with Data-Driven Design to Hub ServicesData drawn from collaborating sources can benefit the patient journey
Latest:
What Makes a Pharmaceutical Industry Leader?Personality assessments identify the traits that enable some pharma researchers to ascend to leadership roles in industry
Latest:
Getting ready for Sunshine Act public dataHow to prepare for reporting and utilizing published data for business and compliance purposes
Latest:
Alleviating go-to market challenges faced by small virtual pharma companiesThese organizations are encouraged to consider all alternatives when planning their packaging, serialization and validation strategies
Latest:
Grappling with the long-term care marketThe geriatric-dominated LTC market is growing, but has unique constraints
Latest:
AstraZeneca to Build $1.5 Billion Antibody Drug Conjugates Manufacturing Plant in SingaporeThe facility, company says, will be its first that covers end-to-end ADC production.
Latest:
Marching up the channel management curveFinancial and business changes are driving an evolution in channel management strategies
Latest:
Laying the foundation for a national system for evidence generationSharing clinical data—EvGen—will improve both drug development and health outcomes analysis
Latest:
HDA calls for withdrawal of FDA’s latest DSCSA guidance on the ‘enhanced drug distribution system’FDA’s recommended guidance is for a system that ‘does not exist, cannot be built by 2023, and poses unacceptable security and compliance risks,’ says alliance
Latest:
How cloud-based IT systems address FDA validation requirementsPaper validation records will disappear in the face of continuous validation
